Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Here ya go...
https://www.sec.gov/answers/listing.htm
depends on the exchange.
Isnt it 90 days for a start-up that isn't selling a product? I believe it's different (easier) for a company already established and selling product.
If you're a long, anything under $5 is a good buy for Titan. We probably will not see it in the $1.75 -1.80 range again.
Don't ban LTG, I want him front and center when TITXF takes off. SPORT is simply a better, more advanced robotic platform than Spider / Surgibot and he knows it. He just likes bust'n chops in this board. Something tells me he's got a little Titan stash in his holdings.
Now, LTG you are still a major shit-stirrer and I doubt Ill ever agree with you again!
#TitanMedical
Actually LTG has a point. Don't get comfortable with the run-up because the large market maker buys can and will short. Milestones, consistent PR and tech print will keep it moving up. Minus that, day traders and shorters are impatient. Be ready for rough patches!
Posilock... You said it will carry through each day (5 to 20 cents) til proper valuation. I give you credit for calling the short-term run-up... good call. But that isn't exactly what you predicted and why I questioned your statement. It fell short on Monday and Tuesday and I dont see it going up 5 to 20 cents A DAY until it's valued appropriately ($4 to $6+ range) like u said it will. We will have plus and minus days. I hope I'm wrong but it's still too volatile and these big orders can reverse in an instant. It will get there, just not convinced it will happen that easy. Mgt could drop a big PR tomorrow or early next week and blow my theory out of the water but I don't think so.
TITXF up, TRXC down...Funny how LTG has disappeared!
Hey, I'm with ya! It's getting exciting again. They've made tbe changes that needed to be made and turned the corner. There will surely be some slow / rough patches ahead, but Titan is on its way. Milestones, milestones, milestones!!! I agree with you that once uplisted, there's no looking back. I think if people still want to get in this thing before it blows up, buying in below $5 pps, while it's still a penny stock, is a hell of an investment!!!
LOL Honeycomb! For the five months Ive been on this board Ive never seen you so giddy.
Go Titan!
NICE!!!!!!!
Again, I cant imagine management agreeing to a buyout that early. They want to see this thing through to the end...PLUS be rewarded for their efforts. If the development stage stays on target, I don't think a pre-FDA approval acquisition is in the cards. Once approved, the bidding will get serious just on market potential alone.
I cant imagine management wanting to sell until it is in a position to do so at a premium. This would most likely be after FDA approval and within the first year or two of active sales. Keep in mind, a company with experience and an established sales force will have a much bigger and more immediate impact on the market than a start-up company. There is no reason why an early investor in Titan cannot continue to own shares in the acquiring company and reap the rewards of increased sales and company value. Id hope to see a company come in with a bid around $30 to $50 per share sometime between 2016 and 2019.
Have not been taking that into account... thanks Cuin.
It depends on when the bidding starts and who the bidders are. This market has such huge potential. Look at what Merck just did... they're paying a 240% premium for Idenix just to strengthen their Hep C portfolio. Titan can position themselves for a premium buyout fairly easily IMO.
Id be fine with a buyout attempt by Intuitive as well.
Great post!
Of course they arent focusing on it now you dolt! They are trying to get SPORT to market asap!
lol, you oughtta get a grip. I hope TRXC does well. I am not in a "pissing match" about the two companies like you are LTG. I have considered buying some TRXC shares myself. I just believe Titan has a better grasp for the direction of the industry. Your "robot" has serious limitations. The SPORT platform can be built upon. They are already discussing haptic feedback for the next generation. Chill out, you act like you designed the thing yourself.
...and the Surgibot platform offers zero potential for future remote applications!
This was posted by Cuin awhile ago...
Devil's advocate is a good thing!
Think about what remote surgery could mean in the future...
Let's say you're a cancer patient and you want/need a particular specialist or you want the procedure done by a surgeon who is doing things "out-of-the-box." What if you are in Topeka, KS and the surgeon is in Brussels, Belgium? Or how about you are a soldier on the front lines in Afghanistan who needs immediate attention?
As for equipment issues, highly trained technicians (and company reps) are on the spot now... Nothing would change.
SPORT is the technology that could pave the way to remote surgical applications.
If you all are planning a trip to Las Vegas now, I'll take a rain-check. I learned my lesson years ago not to count my chickens before they're hatched...
Just ask the Schering-Plough/Merck people how it felt when they launched Clarinex about 15 years ago... They thought they had the next Claritin, had a HUGE 4-day launch party in LA, only to wake up after the party to find the FDA wasn't going to approve it. It didn't get approved for another year. Schering took a major hit! I was a SP pharm rep back then. It wasn't pretty! Just hope you all can keep some perspective.
Long on Titan!
They both offer affordable options over daVinci, 3D viewing and portability. The biggest advantage I see Titan having is remote capability. At some point in the future, surgeons will be able to perform procedures remotely. Surgibot is limited because the surgeon still must work at the patient's side. I find it strange that TRXC tries to promote that aspect of their platform.
Im a big fan of Medtronic! As SPORT moves on in development in the next year, this is going to get quite intetesting!
I'm not sure they really realized the problem they had with investors until the annual meeting. You can thank Point and his friend for bringing these issues up at the meeting.
Operations ramping up? Spill it Point... what's going on? Is it possible they could have the "design freeze" by the end of this year?
Good work Point. You've taken the bull by the horns and it is VERY MUCH appreciated! I've read some of the comments the readers on SA have made regarding both of your write-ups. It's great to read the "chatter" about Titan and it's all thanks to your commitment!
Yes, it was a good day. Successful animal tissue testing is very significant. Point also has done a great job with his write-ups. I think share price should have done a bit better today IMO. I sure as hell hope Posilock is right that it will increase 5 to 20 cents a day moving forward but I'm not holding my breath. He is the same guy who thinks this thing is gonna run up to $300 to $400 ps. It will fluctuate until the next milestone is met or there is other significant info announced. Again, not being negative, Im putting this into proper perspective.
I'm not negative, Im realistic! You're the one who thinks this thing can get to $400 pps. lol
It opened at $1.70 Posilock and closed at $1.74. It's up 4 cents from today's open. Go back and read what I said initially.
I know you aren't a cheerleader for a MA Honeycomb, but a race to consolidate could fetch top dollar for Titan! Will be intetesting to watch this unfold if it really is an industry trend.
Oh Posilock meant Canadian?
It didnt even close up $.05 from today's open PosiLock!
Really? Per day huh?
Point on Seeking Alpha again!
http://seekingalpha.com/article/2270683?source=iphoneportfolioapp_copy
It is huge for the development stage milestones. The two big ones, that will significantly move pps, will be successful human trials and EU approval. The biggest of course will be FDA approval - as long as they stay within the projected timeframe!
$.05 to $.20 per day? For how long?
Wholeheartedly agree!
A pharm rep?